VRTX - VERTEX PHARMACEUTICALS INC / MA
488.29
2.570 0.526%
Share volume: 1,198,359
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$485.72
2.57
0.01%
Summary score
54%
Profitability
59%
Dept financing
8%
Liquidity
75%
Performance
54%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
3.97%
Return on assets
5.56%
Return on sales
41.95%
Return on invested capital
27.97%
Total debt ratio
24.54%
Debt ratio change over timeo
-0.09%
Current Ratio
4.03%
Quick Ratio
3.84%
Cash Position Ratio
3.1%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.2%
Return on assets
4.79%
Return on sales
39.01%
Return on invested capital
-15.46%
Total debt ratio
26.49%
Debt ratio change over timeo
-1.08%
Current Ratio
2.8%
Quick Ratio
2.52%
Cash Position Ratio
1.73%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
4.49%
Return on sales
35.23%
Return on invested capital
0%
Total debt ratio
27.18%
Debt ratio change over time
-1.58%
Current Ratio
2.69%
Quick Ratio
2.35%
Cash Position Ratio
1.28%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-93.53%
Return on assets
-88.64%
Return on sales
-14.26%
Return on invested capital
-32.81%
Total debt ratio
-8.6%
Debt ratio change over time
-0.09%
Current Ratio
15.89%
Quick Ratio
15.24%
Cash Position Ratio
12.56%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VRTX | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 3.97% | 15.71% | 0% | 0% |
| Return on assets | 5.56% | 4.24% | 0% | 0% |
| Return on sales | 41.95% | 28.08% | 0% | 0% |
| Return on invested capital | 27.97% | 9.78% | 0% | 0% |
| Profitability | 81% | 70% | 0% | 0% |
| Total debt ratio | 24.54% | 81.31% | 0% | 0% |
| Debt ratio change over time | -0.09% | -15.58% | 0% | 0% |
| Dept financing | 8% | 25% | 25% | 0% |
| Current Ratio | 2.8% | 1.25% | 0% | 0% |
| Quick Ratio | 2.52% | 0.96% | 0% | 0% |
| Cash Position Ratio | 1.73% | 0.13% | 0% | 0% |
| Liquididy | 75% | 15% | 0% | 0% |
| Short-term ratios | VRTX | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | -9.2% | 17.51% | 0% | 0% |
| Return on assets | 4.79% | 4.29% | 0% | 0% |
| Return on sales | 39.01% | 28.55% | 0% | 0% |
| Return on invested capital | -15.46% | 11.13% | 0% | 0% |
| Profitability | 50% | 91% | 0% | 0% |
| Total debt ratio | 26.49% | 80.84% | 0% | 0% |
| Debt ratio change over time | -1.08% | 4.11% | 0% | 0% |
| Dept financing | 8% | 50% | 0% | 0% |
| Current Ratio | 2.8% | 1.25% | 0% | 0% |
| Quick Ratio | 2.52% | 0.96% | 0% | 0% |
| Cash Position Ratio | 1.73% | 0.13% | 0% | 0% |
| Liquididy | 75% | 23% | 0% | 0% |